Are German Drug Pricing Regulations Chasing Some Drug Makers Away, Causing Them To Withdraw Products…
Bristol Myers Squibb announced it is withdrawing its cancer drug, Opdualag, from the German market. ... This follows bluebird bio's exit from the German and European markets, when it failed to reach price agreements for its beta…